Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
doi: 10.1016/j.jhep.2016.04.025
Mounjaro's sales dip: How cheap generics are redrawing India's GLP-1 market The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive Eli Lilly's Mounjaro posted its first monthly sales drop in India in Marcha Rs 20-crore decline, from roughly Rs 135 crore in February to Rs 114 crorejust days after a clutch of Indian generics entered the country's booming GLP-1 market
Statements Author contributions LY: Conceptualization, Formal Analysis, Investigation, Methodology, Writing original draft, Writing review and editing
Control de Peso Diabetes, control de peso y semaglutida La diabetes es una de las enfermedades crnicas ms frecuentes a nivel mundial y una de las principales preocupaciones de salud en la poblacin adulta
I look forward to seeing you at Restore SD Plastic Surgery
US$ 20.16
US$ 25.91
US$ 29.72
US$ 29.09
US$ 29.17
US$ 22.07
US$ 21.05
